|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.21 EUR | -5.69% |
|
-8.96% | +80.93% |
| May. 09 | Earnings Flash (NAMS) NEWAMSTERDAM PHARMA N.V. Reports Q1 Revenue $1.4M | MT |
| May. 08 | NewAmsterdam Pharma Company N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
NewAmsterdam Pharma Company N.V. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 14.09 million compared to USD 102.69 million a year ago. Net loss was USD 176.94 million compared to USD 22.63 million a year ago.
Basic loss per share from continuing operations was USD 2.15 compared to USD 1.19 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +80.93% | 1.82B | |
| +5.33% | 111B | |
| +12.11% | 105B | |
| -12.56% | 22.34B | |
| -3.70% | 21.93B | |
| -6.03% | 18.59B | |
| -35.21% | 18.12B | |
| -10.86% | 16.96B | |
| +5.10% | 13.7B | |
| +37.57% | 12.45B |
FRAZIER LIFESCIENCES ACQUISITION CORPORATION 
